A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose and assess the safety
and tolerability of escalating doses of BMS-663513 when given in combination with either
radiotherapy alone or radiotherapy plus paclitaxel and carboplatin.